Good resistance of the 2020/2021 revenues

-1%. Confirmation of profitability objectives for fiscal year 2020/2021 and a return to double-digit growth in the current fiscal year - Seite 2

For the 2020/2021 fiscal year, the Group's revenues came to €80.3m (-1%) at current exchange rates, and €81.9m, up 1% at constant exchange rates, driven in particular by a 34% organic increase in revenues generated in North America.

Over the last quarter of the year, in a still difficult global health climate, Generix Group set a new quarterly revenue record at €21.4 million, up 5% on the same period of the previous year (7.1% at constant exchange rates).

Growth over the quarter was mainly driven by:

• sustained license sales activity (+54%), particularly in North America (x3) and France (+40%);
• growth in consulting and services activities, particularly in North America (+36%).

Q4 New SaaS contract signing: € 2,2M (+86%)

	Quarter ended March 31		Var. Q4 2021 vs Q4 2020	12 months ended March 31		Var. 2021 vs 2020
Unaudited (K€)	2021	2020		2021	2020
New SaaS contract signing (ACV*)	2 217	1 191	86%	4 746	3 552	34%

*New contracts signed expressed in ACV (Annual Contract Value), emphasize the average annual complementary revenue to be generated after implementing the contracts in question.

In addition to the good momentum of license sales, the past quarter was also marked by the confirmation of a return to a sustained rate of new SaaS contract signatures (+86%). This trend more than offsets the decline in signatures in the first half of the year. Over 12 months, signing of SaaS contracts increased by 34%.

Among the new SaaS signatures on the Generix Supply Chain Hub platform, the following should be noted:

• a contract in Russia for five new WMS sites for a world leader in the food industry, which Generix Group is supporting in its international deployment;
• a contract in Spain concerning four new warehouses for a leading DIY retailer.

Over the year, the Group signed €4.7 million (+34%) in new contracts, enabling it to generate 6% growth in CMRR*.

Confirmation of profitability objectives for fiscal year 2020/2021

Return to double-digit growth in the current fiscal year

The level of revenues recorded over the past quarter enables the Group to confirm the expected trend in profitability for the 2020/2021 financial year, which should be in line with that observed in the first half of the year, with a controlled decline in the EBITDA margin, excluding the impact of the effort made in research and development.